Athyrium Opportunities III Co-Invest 1 LP 13D and 13G filings for Biora Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-26 9:30 pm Purchase |
2025-03-24 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities III Co-Invest 1 LP | 3,416,032 49.900% |
841,579 (+32.69%) |
Filing |
| 2024-10-09 5:40 pm Purchase |
2024-10-07 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities III Co-Invest 1 LP | 2,574,453 49.900% |
30,716 (+1.21%) |
Filing |
| 2024-09-13 10:37 am Unchanged |
2024-09-10 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities III Co-Invest 1 LP | 2,543,737 49.900% |
0 (Unchanged) |
Filing |
| 2024-08-14 9:58 pm Purchase |
2024-08-12 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities III Co-Invest 1 LP | 2,543,737 49.900% |
58,291 (+2.35%) |
Filing |
| 2024-07-08 9:42 pm Purchase |
2024-07-03 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities III Co-Invest 1 LP | 2,485,446 49.900% |
2,485,446 (New Position) |
Filing |